Association of interleukin 1β polymorphisms and haplotypes with Alzheimer's disease

Journal of Neuroimmunology

Volumn 247, Issue 1-2, 2012, Pages 59-62

  Payão, Spencer Luiz Marques ^a,c   Gonçalves, Gisela Moraes ^a   de Labio, Roger William ^c   Horiguchi, Lie ^c   Mizumoto, Igor ^c   Rasmussen, Lucas Trevizani ^c   de Souza Pinhel, Marcela Augusta ^d   Silva Souza, Dorotéia Rossi ^d   Bechara, Marcelo Dib ^e   Chen, Elizabeth ^b   Mazzotti, Diego Robles ^b   Ferreira Bertolucci, Paulo Henrique ^b   Cardoso Smith, Marília de Arruda ^b  

^a UNIVERSIDADE DO SAGRADO CORAÇÃO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FACULDADE DE MEDICINA DE MARÍLIA   (Brazil)

^d FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^e Universidade de Marilia   (Brazil)

Author keywords

Alzheimer's disease; Haplotypes; Interleukin 1 ; Polymorphisms; Receptor antagonist

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAZIL; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; INTERLEUKIN 1 RECEPTOR ANTAGONIST GENE; INTERLEUKIN 1BETA GENE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; VARIABLE NUMBER OF TANDEM REPEAT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAZIL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC;

EID: 84860833662     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.03.012     Document Type: Article

References (39)

1. Bales K.R., Verina T., Cummins D.J., Du Y., Dodel R.C., Saura J., Fishman C.E., DeLong C.A., Piccardo P., Petegnief V., et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:15233-15238.
2. Barger S.W., Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997, 388:878-881.
3. Bi S., Wang D.S., Li G.L., Pan S.H. Analysis of interleukin-1 receptor antagonist gene polymorphism in Chinese patients with Alzheimer's disease. Chin. Med. Sci. J. 2004, 19(2):93-96.
4. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
5. Bosco P., Gueant-Rodriguez R.M., Anello G., Romano A., Namour B., Spada R.S., Caraci F., Tringali G., Ferri R., Gueant J.L. Association of IL-1 RN*2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2004, 75:1036-1038.
6. Di-Bona D., Plaia A., Vasto S., Cavallone L., Lescai F., Franceschi C., Licastro F., Colonna-Romano G., Lio D., Candore G., Caruso C. Association between the interleukin-1! polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. Brain Res. Rev. 2008, 59:155-163.
7. Déniz-Naranjo M.C., Munõz-Fernandez C., Alemany-Rodríguez M.J., Pérez-Vieitez M.C., Aladro-Benito Y., Irurita-Latasa J., Sánchez-García F. Cytokine IL-1 beta but not IL-1 alpha promoter polymorphism is associated with Alzheimer disease in a population from the Canary Islands, Spain. Eur. J. Neurol. 2008, 15:1080-1084.
8. Dursun E., Gezen-Ak D., Eker E., Ertan T., Engin F., Hanagasi H., Gurvit H., Emre M., Yilmazer S. Presenilin-1 gene intronic polymorphism and late-onset Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 2008, 21:268-273.
9. Ehl C., Kolsch H., Ptok U., Jessen F., Schmitz S., Frahnert C., Schlosser R., Rao M.L., Maier W., Heun R. Association of an interleukin-1beta gene polymorphism at position -511 with Alzheimer's disease. Int. J. Mol. Med. 2003, 11:235-238.
10. Emery A.E.H. Methodology in Medical Genetics - an Introduction to Statistical Methods 1986, Longman Group Ltd., Edinburgh.
11. Feulner T.M., Laws S.M., Friedrich P., Wagenpfeil S., Wurst S.H., Riehle C., Kuhn K.A., Krawczak M., Schreiber S., Nikolaus S., Forstl H., Kurz A., Riemenschneider M. Examination of the current top candidate genes for AD in a genome-wide association study. Mol. Psychiatry 2010, 15:756-766.
12. Forlenza O.V., Diniz B.S., Talib L.L., Mendonca V.A., Ojopi E.B., Gattaz W.F., Teixeira A.L. Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 2009, 28:507-512.
13. Griffin W.S., Liu L., Li Y., Mrak R.E., Barger S.W. Interleukin-1 mediates Alzheimer and Lewy body pathologies. J. Neuroinflammation 2006, 3:5.
14. Griffin W.S., Nicoll J.A., Grimaldi L.M., Sheng J.G., Mrak R.E. The pervasiveness of interleukin-1 in Alzheimer pathogenesis: a role for specific polymorphisms in disease risk. Exp. Gerontol. 2000, 35:481-487.
15. Grimaldi L.M., Casadei V.M., Ferri C., Veglia F., Licastro F., Annoni G., Biunno I., De Bellis G., Sorbi S., Mariani C., Canal N., Griffin W.S., Franceschi M. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann. Neurol. 2000, 47:361-365.
16. Hachinski V.C., Iliff L.D., Zilhka E., Du Boulay G.H., McAllister V.L., Marshall J., Russell R.W., Symon L. Cerebral blood flow in dementia. Arch. Neurol. 1975, 32:632-637.
17. Kay D.W. The genetics of Alzheimer's disease. Br. Med. Bull. 1986, 42:19-23.
18. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 1985, 42:1097-1105.
19. Klimkowicz-Mrowiec A., Marona M., Wolkow P., Maruszak A., Styczynska M., Barcikowska M., Zekanowski C., Szczudlik A., Slowik A. Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population. Dement. Geriatr. Cogn. Disord. 2009, 28:461-464.
20. Kornman K.S. Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am. J. Clin. Nutr. 2006, 83:475S-483S.
21. Licastro F., Pedrini S., Ferri C., Casadei V., Govoni M., Pession A., Sciacca F.L., Veglia F., Annoni G., Bonafe M., Olivieri F., Franceschi C., Grimaldi L.M. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann. Neurol. 2000, 48:388-391.
22. Liu L., Aboud O., Jones R.A., Mrak R.E., Griffin S.E., Barger S.W. Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors. J. Neuroinflammation 2011, 8:175.
23. Ma S.L., Tang N.L., Lam L.C., Chiu H.F. Lack of association of the interleukin-1beta gene polymorphism with Alzheimer's disease in a Chinese population. Dement. Geriatr. Cogn. Disord. 2003, 16:265-268.
24. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
25. Mrak R.E., Griffinbc W.S. The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease. Neurobiol. Aging 2001, 22:915-922.
26. Nicoll J.A., Mrak R.E., Graham D.I., Stewart J., Wilcock G., MacGowan S., Esiri M.M., Murray L.S., Dewar D., Love S., Moss T., Griffin W.S. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann. Neurol. 2000, 47:365-368.
27. Pericak-Vance M.A., Bebout J.L., Gaskell P.C., Yamaoka L.H., Hung W.Y., Alberts M.J., Walker A.P., Bartlett R.J., Haynes C.A., Welsh K.A., et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am. J. Hum. Genet. 1991, 48:1034-1050.
28. Ravaglia G., Paola F., Maioli F., Martelli M., Montesi F., Bastagli L., Bianchin M., Chiappelli M., Tumini E., Bolondi L., Licastro F. Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study. Exp. Gerontol. 2006, 41:85-92.
29. Sala G., Galimberti G., Canevari C., Raggi M.E., Isella V., Facheris M., Appollonio I., Ferrarese C. Peripheral cytokine release in Alzheimer patients: correlation with disease severity. Neurobiol. Aging 2003, 24:909-914.
30. Santtila S., Savinainen K., Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand. J. Immunol. 1998, 47:195-198.
31. Sciacca F.L., Ferri C., Licastro F., Veglia F., Biunno I., Gavazzi A., Calabrese E., Martinelli Boneschi F., Sorbi S., Mariani C., Franceschi M., Grimaldi L.M. Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease. Neurobiol. Aging 2003, 24:927-931.
32. Sheng J.G., Mrak R.E., Griffin W.S. Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression. Neuropathol. Appl. Neurobiol. 1996, 22:334-341.
33. Sheng J.G., Ito K., Skinner R.D., Mrak R.E., Rovnaghi C.R., Van Eldik L.J., Griffin W.S. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging 1996, 17:761-766.
34. Strittmatter W.J., Saunders A.M., Goedert M., Weisgraber K.H., Dong L.M., Jakes R., Huang D.Y., Pericak-Vance M., Schmechel D., Roses A.D. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:11183-11186.
35. Wang H.K., Hsu W.C., Fung H.C., Lin J.C., Hsu H.P., Wu Y.R., Hsu Y., Hu F.J., Lee-Chen G.J., Chen C.M. Interleukin-1alpha and -1beta promoter polymorphisms in Taiwanese patients with dementia. Dement. Geriatr. Cogn. Disord. 2007, 24:104-110.
36. Wang W.F., Liao Y.C., Wu S.L., Tsai F.J., Lee C.C., Hua C.S. Association of interleukin-I beta and receptor antagonist gene polymorphisms with late onset Alzheimer's disease in Taiwan Chinese. Eur. J. Neurol. 2005, 12:609-613.
37. Wu S.Z., Bodles A.M., Porter M.M., Griffin W.S., Basile A.S., Barger S.W. Induction of serine racemase expression and d-serine release from microglia by amyloid beta-peptide. J. Neuroinflammation 2004, 1:2.
38. Wu S., Basile A.S., Barger S.W. Induction of serine racemase expression and d-serine release from microglia by secreted amyloid precursor protein (sAPP). Curr. Alzheimer Res. 2007, 4:243-251.
39. Yucesoy B., Peila R., White L.R., Wu K.M., Johnson V.J., Kashon M.L., Luster M.I., Launer L.J. Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study. Neurobiol. Aging 2006, 27:211-217.